Design, synthesis and biological evaluation of 7-(aryl)-2,3-dihydro-[1,4]dioxino[2,3-g]quinoline derivatives as potential Hsp90 inhibitors and anticancer agents. 2017

Sina Omid Malayeri, and Khalil Abnous, and Atefeh Arab, and Maryam Akaberi, and Soghra Mehri, and Afshin Zarghi, and Razieh Ghodsi
Biotechnology Research Center, Mashhad University of Medical Sciences, Mashhad, Iran; Department of Medicinal Chemistry, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran.

A new series of quinoline analogues was designed and synthesized as Hsp90 inhibitors. The cytotoxic activity of the synthesized compounds was evaluated against three human cancer cell lines including MCF-7 (human breast cancer cells), DU145 (human prostate cancer cell lines), and A549 (adenocarcinomic human alveolar basal epithelial cells). Some of our compounds (13a-13f) showed significant cytotoxic activity on MCF-7 cells. The most potent anti-proliferative compounds were also tested against Her2, a client protein of Hsp90. Compound 13d that demonstrated the highest antiproliferative activity in the series, was found the most potent one for both Her2 protein degradation and Hsp70 protein induction as well. Molecular modeling studies displayed possible mode of interaction between this compound and N-terminal ATP-binding site of Hsp90.

UI MeSH Term Description Entries
D008958 Models, Molecular Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures. Molecular Models,Model, Molecular,Molecular Model
D011804 Quinolines
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004354 Drug Screening Assays, Antitumor Methods of investigating the effectiveness of anticancer cytotoxic drugs and biologic inhibitors. These include in vitro cell-kill models and cytostatic dye exclusion tests as well as in vivo measurement of tumor growth parameters in laboratory animals. Anticancer Drug Sensitivity Tests,Antitumor Drug Screens,Cancer Drug Tests,Drug Screening Tests, Tumor-Specific,Dye Exclusion Assays, Antitumor,Anti-Cancer Drug Screens,Antitumor Drug Screening Assays,Tumor-Specific Drug Screening Tests,Anti Cancer Drug Screens,Anti-Cancer Drug Screen,Antitumor Drug Screen,Cancer Drug Test,Drug Screen, Anti-Cancer,Drug Screen, Antitumor,Drug Screening Tests, Tumor Specific,Drug Screens, Anti-Cancer,Drug Screens, Antitumor,Drug Test, Cancer,Drug Tests, Cancer,Screen, Anti-Cancer Drug,Screen, Antitumor Drug,Screens, Anti-Cancer Drug,Screens, Antitumor Drug,Test, Cancer Drug,Tests, Cancer Drug,Tumor Specific Drug Screening Tests
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D015195 Drug Design The molecular designing of drugs for specific purposes (such as DNA-binding, enzyme inhibition, anti-cancer efficacy, etc.) based on knowledge of molecular properties such as activity of functional groups, molecular geometry, and electronic structure, and also on information cataloged on analogous molecules. Drug design is generally computer-assisted molecular modeling and does not include PHARMACOKINETICS, dosage analysis, or drug administration analysis. Computer-Aided Drug Design,Computerized Drug Design,Drug Modeling,Pharmaceutical Design,Computer Aided Drug Design,Computer-Aided Drug Designs,Computerized Drug Designs,Design, Pharmaceutical,Drug Design, Computer-Aided,Drug Design, Computerized,Drug Designs,Drug Modelings,Pharmaceutical Designs
D015394 Molecular Structure The location of the atoms, groups or ions relative to one another in a molecule, as well as the number, type and location of covalent bonds. Structure, Molecular,Molecular Structures,Structures, Molecular
D045744 Cell Line, Tumor A cell line derived from cultured tumor cells. Tumor Cell Line,Cell Lines, Tumor,Line, Tumor Cell,Lines, Tumor Cell,Tumor Cell Lines

Related Publications

Sina Omid Malayeri, and Khalil Abnous, and Atefeh Arab, and Maryam Akaberi, and Soghra Mehri, and Afshin Zarghi, and Razieh Ghodsi
March 2004, Bioorganic & medicinal chemistry,
Sina Omid Malayeri, and Khalil Abnous, and Atefeh Arab, and Maryam Akaberi, and Soghra Mehri, and Afshin Zarghi, and Razieh Ghodsi
May 2021, Bioorganic chemistry,
Sina Omid Malayeri, and Khalil Abnous, and Atefeh Arab, and Maryam Akaberi, and Soghra Mehri, and Afshin Zarghi, and Razieh Ghodsi
October 2005, Archiv der Pharmazie,
Sina Omid Malayeri, and Khalil Abnous, and Atefeh Arab, and Maryam Akaberi, and Soghra Mehri, and Afshin Zarghi, and Razieh Ghodsi
June 2000, Organic letters,
Sina Omid Malayeri, and Khalil Abnous, and Atefeh Arab, and Maryam Akaberi, and Soghra Mehri, and Afshin Zarghi, and Razieh Ghodsi
May 2019, Bioorganic & medicinal chemistry letters,
Sina Omid Malayeri, and Khalil Abnous, and Atefeh Arab, and Maryam Akaberi, and Soghra Mehri, and Afshin Zarghi, and Razieh Ghodsi
January 2019, Anti-cancer agents in medicinal chemistry,
Sina Omid Malayeri, and Khalil Abnous, and Atefeh Arab, and Maryam Akaberi, and Soghra Mehri, and Afshin Zarghi, and Razieh Ghodsi
December 2019, European journal of medicinal chemistry,
Sina Omid Malayeri, and Khalil Abnous, and Atefeh Arab, and Maryam Akaberi, and Soghra Mehri, and Afshin Zarghi, and Razieh Ghodsi
September 2019, European journal of medicinal chemistry,
Sina Omid Malayeri, and Khalil Abnous, and Atefeh Arab, and Maryam Akaberi, and Soghra Mehri, and Afshin Zarghi, and Razieh Ghodsi
June 2006, Bioorganic & medicinal chemistry letters,
Sina Omid Malayeri, and Khalil Abnous, and Atefeh Arab, and Maryam Akaberi, and Soghra Mehri, and Afshin Zarghi, and Razieh Ghodsi
February 2018, Bioorganic & medicinal chemistry letters,
Copied contents to your clipboard!